| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.015 | 0.8 |